Shirley Xerxes was one of the first in the UK to receive the injectable form of Keytruda on the NHS A new injectable form of ...

The Department of Health says it is "aware" of the jab and is "exploring" how it can be made available "as soon as possible".

What is Keytruda and how does it work? Experts explain the cancer immunotherapy as a global investigation raises concerns over pricing, patents, and access in India.

Tens of thousands of patients could benefit from a ‘rapid’ new immunotherapy jab on the NHS for over a dozen different cancers, which can be given in just 60 seconds. The NHS is rolling out a new ...

Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.

First approved by the US FDA in 2014 for advanced skin cancer, Keytruda is now used globally for certain lung cancers, cervical cancer, renal cell cancer and aggressive breast cancer, among others.

New NHS cancer jab means treatment could take minutes rather than hours - Until now, patients have had to spend hours on a ...

The KEYNOTE-671 trial showed a 71% 36-month overall survival rate with perioperative Keytruda, compared to 64% with placebo. FDA approvals for Keytruda, Imfinzi, and Opdivo in perioperative settings ...

A landmark moment in cancer treatment was announced today, May 4, 2026, as the NHS in England rolled out a revolutionary ...

In a yearlong investigation led by the International Consortium of Investigative Journalists, reporters from more than 37 ...